Obesity
Applied Evidence
Transitioning patients with developmental disabilities to adult care
The pre-visit questionnaire, instructive videos, and Web resources detailed here can help you play a pivotal role in planning, commencing, and...
Latest News
Admissions for eating disorders double in pandemic
More adolescents have needed help for eating disorders, which has exacerbated a treatment bottleneck.
Conference Coverage
ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows
The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an...
Conference Coverage
New agents for youth-onset type 2 diabetes ‘finally in sight’
‘A number of clinical trials of antidiabetic pharmacologic agents in diabetic youth have been completed, demonstrating safety and efficacy, and a...
Latest News
Can overweight docs really give credible weight loss advice?
“I have had patients come to me saying, ‘I used to see a different weight loss doctor who was not heavy. But how can he understand what I’m going...
From the Journals
Meta-analysis supports cardiovascular benefits of EPA
Omega-3 fatty acids improved cardiovascular outcomes, with a greater risk reduction in studies of eicosapentaenoic acid alone rather than combined...
Practice Alert Podcast
Healthy weight gain in pregnancy: What the USPSTF recommends
What is considered “healthy weight gain” in pregnancy? In this month’s audio, Dr. Campos-Outcalt describes the US Preventive Services Task Force’s...
Guidelines
AGA Clinical Practice Update: Early complications after bariatric/metabolic surgery
The seven advice statements range from a call for high familiarity with interventions to specific approaches for managing postoperative leaks.
Conference Coverage
Semaglutide 2.4 mg ‘likely to usher in a new era’ in obesity treatment
Clinical experience with this drug will grow rapidly over the next few years, one expert predicts, and new combination drugs are near, so...
Conference Coverage
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...
Conference Coverage
‘Staggering’ doubling of type 2 diabetes in children during pandemic
Two new studies show a shocking increase in type 2 diabetes among U.S. children during the pandemic, with increased severity at presentation....